How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How are Companion Diagnostics Considered in Economic Evaluations of Oncology Treatments? A Review of Health Technology Assessments

Published:2022-07-06 Issue:5 Volume:6 Page:637-646
ISSN:2509-4262
Container-title:PharmacoEconomics - Open
language:en
Short-container-title:PharmacoEconomics Open

Author:

Gomez Montero Melissa,El Alili Houcine,Hashim Mahmoud,Wigfield Peter,Dimova Mariya,Riley Ralph,Pascoe Katie^ORCID

Funder

Janssen Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy,Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s41669-022-00350-6.pdf

Reference50 articles.

1. Schmidt KT, Chau CH, Price DK, et al. Precision oncology medicine: the clinical relevance of patientspecific biomarkers used to optimize cancer treatment. J Clin Pharmacol. 2016;1484–99.

2. Wurcel V, Perche O, Lesteven D, et al. The value of companion diagnostics: overcoming access barriers to transform personalised health care into an affordable reality in Europe. Public Health Genomics. 2016;19:137–43.

3. Companion Diagnostics | FDA [Internet]. [cited 2019 May 1]. Available from: https://www.fda.gov/medical-devices/vitro-diagnostics/companion-diagnostics.

4. Byron SK, Crabb N, George E, et al. The health technology assessment of companion diagnostics: Experience of nice. Clin Cancer Res. 2014;20.

5. Doble B. Economic evaluation of companion and complementary diagnostics. Companion and complementary diagnostics: from biomarker discovery to clinical implementation. 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP